No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)

Journal of Obstetrics and Gynaecology Canada

Volumn 39, Issue 8, 2017, Pages e130-e137

  Maxwell, Cynthia ^a   McGeer, Alison ^a   Tai, Kin Fan Young ^a   Sermer, Mathew ^a  

^a NONE   (Canada)

Author keywords

acute respiratory distress syndrome (ARDS); maternal morbidity; maternal mortality; neonatal care; perinatal morbidity; perinatal mortality; pregnancy; Severe acute respiratory syndrome (SARS)

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; RECOMBINANT INTERFERON; RIBAVIRIN;

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CESAREAN SECTION; CORONAVIRUS INFECTION; DRUG MEGADOSE; EPIDEMIC; FETUS DEATH; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; INTRAUTERINE GROWTH RETARDATION; MATERNAL MORTALITY; MORTALITY RATE; NEWBORN; NEWBORN DEATH; PNEUMONIA; POSTNATAL CARE; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; RESUSCITATION; SEVERE ACUTE RESPIRATORY SYNDROME; CANADA; FEMALE; HEALTH CARE PERSONNEL; ORGANIZATION AND MANAGEMENT; PATIENT ISOLATION; PERINATAL CARE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PROCEDURES;

CANADA; FEMALE; HEALTH PERSONNEL; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; PATIENT ISOLATION; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 85024090916     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jogc.2017.04.024     Document Type: Article

References (40)

1. World Health Organization. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/en/index.html Accessed May 20, 2004.
2. Health Canada. Canadian SARS numbers, 3 September 2003. Available at: http://www.sars.gc.ca Accessed May 20, 2004.
3. Ksiazek, T.J., Erdman, T., Goldsmith, C.S., et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348 (2003), 1953–1966.
4. Drosten, C., Gunther, S., Preiser, W., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348 (2003), 1967–1976.
5. Peiris, J.S., Lai, S.T., Poon, L.L., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 (2003), 1319–1325.
6. Poutanen, S.M., Low, D.E., Henry, B., et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348 (2003), 1995–2005.
7. Seto, W.H., Tsang, D., Yung, R.W., et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome. Lancet 361 (2003), 1519–1520.
8. Yudin, M.H., Steele, D.M., Sgro, M.D., et al. Severe acute respiratory syndrome in pregnancy. Obstet Gynecol 105 (2005), 124–127.
9. Lee, N., Hui, D., Wu, A., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med, 2003, 1986–1994.
10. Vu, H.T., Leitmeyer, K.C., Le, D.H., et al. Clinical description of a completed outbreak of SARS in Vietnam, February–May 2003. Emerg Infect Dis 10 (2004), 334–338.
11. Quah, S.R., Hin-Peng, L., Crisis prevention and management during SARS outbreak, Singapore. Emerg Infect Dis 10 (2004), 364–368.
12. From the Centers for Disease Control and Prevention. Update: outbreak of severe acute respiratory syndrome—worldwide, 2003. JAMA 289 (2003), 1918–1920.
13. Hsieh, Y.H., Chen, C.W., Hsu, S.B., SARS outbreak, Taiwan, 2003. Emerg Infect Dis 10 (2004), 201–206.
14. Health Canada. Management of severe acute respiratory sydrome (SARS) in adults: interim guidance for health care providers. Health Canada website, July 2, 2003 Available at: http://www.sars.gc.ca Accessed May 20, 2004.
15. Booth, C.M., Matukas, L.M., Tomlinson, G.A., et al. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA 289 (2003), 2801–2809.
16. Fowler, B.R., Lapinsky, S.E., Hallett, D., et al. Critically ill patients with severe acute respiratory syndrome. JAMA 290 (2003), 367–373.
17. Benedetti, T.J., Valle, R., Ledger, W.J., Antepartum pneumonia in pregnancy. Obstet Gynecol 144 (1982), 413–417.
18. Madinger, N.E., Greenspoon, J.S., Eilrodt, A.G., Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?. Am J Obstet Gynecol 161 (1989), 657–662.
19. Berkowitz, K., LaSala, A., Risk factors associated with the increasing prevalence of pneumonia during pregnancy. Am J Obstet Gynecol 163 (1990), 981–985.
20. Visscher, H.C., Visscher, R.D., Indirect obstetric deaths in the state of Michigan 1960–1968. Am J Obstet Gynecol 109 (1971), 1187–1196.
21. Finland, M., Dublin, T.D., Pneumococcal pneumonias complicating the pregnancy and puerperium. JAMA 250 (1983), 1027–1032.
22. Rigby, F.B., Pastorek, J.G., Pneumonia during pregnancy. Clin Obstet Gynecol 39 (1996), 107–119.
23. Sargent, I.L., Redman, C., Immunobiologic adaptations of pregnancy. Reece, E.A., Hobbins, J.C., Mahoney, M.J., et al. (eds.) Medicine of the fetus and mother, 1992, JB Lippincott Company, Philadelphia, 317–327.
24. Nyhan, D., Bredin, C., Quigley, C., Acute respiratory failure in pregnancy due to staphylococcal pneumonia. Ir Med J 76 (1983), 320–321.
25. Weinberger, S., Weiss, S., Cohen, W., et al. Pregnancy and the lung. Am Rev Respir Dis 121 (1980), 559–581.
26. Leontic, E., Respiratory disease in pregnancy. Med Clin North Am 61 (1977), 111–128.
27. McKinney, P., Volkert, P., Kaufman, J., Fatal swine influenza pneumonia during late pregnancy. Arch Intern Med 150 (1990), 213–215.
28. Larsen, J.W., Influenza and pregnancy. Clin Obstet Gynecol 25 (1982), 599–603.
29. Eickhoff, T.C., Sherman, I.L., Serfling, R.E., Observations on excess mortality associated with epidemic influenza. JAMA 176 (1961), 776–782.
30. Balducci, J., Rodis, J.F., Rosengren, S., et al. Pregnancy outcome following first-trimester varicella infection. Obstet Gynecol 79 (1992), 5–6.
31. Pastuszak, A.L., Levy, M., Schick, B., et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 330 (1994), 901–905.
32. Wong, S.F., Chow, K.M., de Swiet, M., Severe acute respiratory syndrome and pregnancy. BJOG 110 (2003), 641–642.
33. So, L.K.-Y., Lau, A.C., Yam, L.Y., et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 361 (2003), 1615–1617.
34. Fujii, T., Nakamura, T., Iwamoto, A., Current concepts in SARS treatment. J Infect Chemother 10 (2004), 1–7.
35. Cinatl, J., Morgenstern, B., Bauer, G., et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361 (2003), 2045–2046.
36. Knowles, S.R., Phillips, E.J., Dresser, L., et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis 37 (2003), 1139–1142.
37. Cinatl, J., Morgenstern, B., Bauer, G., et al. Treatment of SARS with human interferons. Lancet 362 (2003), 293–294.
38. Stroher, U., DiCaro, A., Li, Y., et al. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha. J Infect Dis 189 (2004), 1164–1167.
39. Haines, C.J., The effect of Severe Acute Respiratory Syndrome on a hospital obstetrics and gynaecology service. BJOG 110 (2003), 643–645.
40. Woolf, S.H., Battista, R.N., Angerson, G.M., et al., Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 169 (2003), 207–208.